Abiopharma

US National Telecom, Inc a Florida based corporation is actively looking to acquire real estate investments that produce positive cash flow results. The company was established in 1999 and was formerly know as Yi Wan Group. The company has an office located in Miami Florida and plans to open other offices within Florida and other markets where deemed necessary. The mission is to invest in highly undervalued and distressed properties that are under market value and are well below reconstruction cost in todays market.

Additional info from OTC:
The company designs, brands, distributes and sells various science based nutritional products for the consumer packaged goods industry in N. America. The flag ship brand Rejuvenate is a patented formulation designed to help prevent muscle loss due to aging (Sarcopenia). It is combination of essential amino acids that has been developed over 17 years though 25 clinical studies. The company uses contract manufacturers in the United States to product all of its products. The product is available in a powdered format as well as a ready to drink beverage. The products are currently distributed and sold through food drug mass retailers in N. America (Walgreens, CVS, SAMs Club) as well as via e-commerce platforms, i.e. Amazon.com. The company also distributes and sells a sports nutrition brand, JAKTRX, which is sold via e-commerce in N. America. The JAKTRX brand is primarily protein powders and amino acid products. The company is continuing to use R&D to expand its product offerings in to multiple nutritional categories.

Additional info from OTC:
US National Telecom, Inc a Florida based corporation is actively looking to acquire real estate investments that produce positive cash flow results. The company was established in 1999 and was formerly know as Yi Wan Group. The company has an office located in Miami Florida and plans to open other offices within Florida and other markets where deemed necessary. The mission is to invest in highly undervalued and distressed properties that are under market value and are well below reconstruction cost in todays market.